Menu

Beyond 3-D: Recapitulating Nature for Optimal Bioproduction

FiberCell Systems invites you to join them for an educational webinar. 

Apr 15, 2018
The Scientist Creative Services Team

Beyond 3-D: Recapitulating Nature for Optimal Bioproduction from thescientistllc on Vimeo.

When cells are your factory, it’s imperative to ensure that they are kept under the right conditions throughout the life of the culture. Standard 2-D and 3-D culture systems, whether dish-, bag-, roller bottle-, or bioreactor-based, all share the same limitations; these cultures fail to keep the cells in tissue-like contact with neighboring cells, depriving them of important signaling cues. Hollow fiber bioreactors (HFBR) are able to promote a physiologically relevant interaction between cells while enabling product retrieval without perturbation. Learn more about HFBRs from FiberCell Systems, the sponsor of this webinar event, and learn how your standard methods are letting you down by design. Bring your questions and comments; FiberCell has the answers you seek.

Topics to be covered:

  • The spatial and nutritional constraints faced by standard cultures, and how HFBRs address them
  • Using HFBRs to generate monoclonal antibodies, exosomes, difficult-to-express proteins, and more

Meet the Speakers:

John Cadwell
CEO
FiberCell Systems

 

 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.